Quadrant Capital Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-515
| Closed | -$7K | – | 1692 |
|
|
2025
Q1 | $7K | Buy |
+515
| New | +$7K | ﹤0.01% | 2287 |
|
|
2024
Q1 | – | Sell |
-19
| Closed | -$408 | – | 2737 |
|
|
2023
Q4 | $408 | Buy |
19
+12
| +171% | +$258 | ﹤0.01% | 2632 |
|
|
2023
Q3 | $145 | Buy |
+7
| New | +$145 | ﹤0.01% | 2662 |
|
|
2023
Q1 | – | Sell |
-40
| Closed | -$1.11K | – | 2743 |
|
|
2022
Q4 | $1.11K | Sell |
40
-10
| -20% | -$278 | ﹤0.01% | 2526 |
|
|
2022
Q3 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 2361 |
|
|
2021
Q4 | – | Sell |
-3
| Closed | – | – | 2547 |
|
|
2021
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 2532 |
|